MedTrace Logo

Evaluating the Impact of Senior Companion Programs

NCT05368480 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1040

Last updated 2022-06-01

No results posted yet for this study

Summary

Senior Companion Programs (SCP) facilitate partnerships between community volunteers and local homebound seniors. Seniors served by the SCP will be provided with a companion who will conduct weekly visits with them, help with meal preparation or deliveries, provide transportation, assist with simple housekeeping, and socialize with the client amongst other tasks. These services are directed towards helping the senior client continue living independently in their own home instead of moving into an assisted living or nursing home. The SCP model is being evaluated to determine the impact of the services on the client's overall well-being and independent living status.

Conditions

  • Aging
  • Disabilities Multiple

Interventions

OTHER

Senior Companion Program

Receives a companion to socialize with them, help with daily tasks, etc.

Sponsors & Collaborators

  • Health Association of Niagara County, Inc.

    collaborator UNKNOWN

  • Catholic Charities

    collaborator OTHER

  • Georgia Southern University

    collaborator OTHER

  • The Evangelical Lutheran Good Samaritan Society

    collaborator UNKNOWN

  • Positive Maturity, Inc.

    collaborator UNKNOWN

  • William Evans

    lead OTHER

Principal Investigators

  • William N Evans, PhD · University of Notre Dame

  • Sarah Kroeger, PhD · University of Notre Dame

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05368480 on ClinicalTrials.gov